Axogen, Inc. Common Stock AXGN
HEALTHCARE · MEDICAL DEVICESi
Market dataready · fetched 2026-11-12T02:05:07.528Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T00:52:22.596472824Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-12T01:59:42.386163+00:00
Axogen, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 51.81 | 97.6% | 13.2% | |||
| 25Δ | 53.58 | 89.1% | 10.6% | |||
| 30Δ | 63.76 | 87.6% | 11.4% | 55.14 | 81.1% | 8.3% |
| 35Δ | 62.49 | 84.7% | 9.7% | 55.87 | 75.0% | 7.3% |
| 40Δ | 61.21 | 81.8% | 8.0% | 56.59 | 69.0% | 6.3% |
| 45Δ | 59.95 | 79.1% | 6.4% | 57.32 | 63.0% | 5.2% |
| 50Δ | 58.96 | 81.1% | 5.7% | 58.04 | 56.9% | 4.2% |
| 55Δ | 57.97 | 83.0% | 5.0% | 58.77 | 50.9% | 3.2% |
| 60Δ | 56.97 | 84.9% | 4.3% | 59.50 | 44.8% | 2.2% |
| 65Δ | 55.98 | 86.8% | 3.6% | 60.26 | 40.9% | 1.4% |
| 70Δ | 54.97 | 88.8% | 2.9% | 61.12 | 41.6% | 1.1% |
| 75Δ | 53.14 | 97.8% | 2.5% | 61.98 | 42.3% | 0.9% |
| 80Δ | 51.32 | 106.8% | 2.1% | 62.84 | 43.0% | 0.7% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 51.81
- IV
- 97.6%
- B/E move
- 13.2%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 53.58
- IV
- 89.1%
- B/E move
- 10.6%
30Δ
- Pseudo strike
- 63.76
- IV
- 87.6%
- B/E move
- 11.4%
- Pseudo strike
- 55.14
- IV
- 81.1%
- B/E move
- 8.3%
35Δ
- Pseudo strike
- 62.49
- IV
- 84.7%
- B/E move
- 9.7%
- Pseudo strike
- 55.87
- IV
- 75.0%
- B/E move
- 7.3%
40Δ
- Pseudo strike
- 61.21
- IV
- 81.8%
- B/E move
- 8.0%
- Pseudo strike
- 56.59
- IV
- 69.0%
- B/E move
- 6.3%
45Δ
- Pseudo strike
- 59.95
- IV
- 79.1%
- B/E move
- 6.4%
- Pseudo strike
- 57.32
- IV
- 63.0%
- B/E move
- 5.2%
50Δ
- Pseudo strike
- 58.96
- IV
- 81.1%
- B/E move
- 5.7%
- Pseudo strike
- 58.04
- IV
- 56.9%
- B/E move
- 4.2%
55Δ
- Pseudo strike
- 57.97
- IV
- 83.0%
- B/E move
- 5.0%
- Pseudo strike
- 58.77
- IV
- 50.9%
- B/E move
- 3.2%
60Δ
- Pseudo strike
- 56.97
- IV
- 84.9%
- B/E move
- 4.3%
- Pseudo strike
- 59.50
- IV
- 44.8%
- B/E move
- 2.2%
65Δ
- Pseudo strike
- 55.98
- IV
- 86.8%
- B/E move
- 3.6%
- Pseudo strike
- 60.26
- IV
- 40.9%
- B/E move
- 1.4%
70Δ
- Pseudo strike
- 54.97
- IV
- 88.8%
- B/E move
- 2.9%
- Pseudo strike
- 61.12
- IV
- 41.6%
- B/E move
- 1.1%
75Δ
- Pseudo strike
- 53.14
- IV
- 97.8%
- B/E move
- 2.5%
- Pseudo strike
- 61.98
- IV
- 42.3%
- B/E move
- 0.9%
80Δ
- Pseudo strike
- 51.32
- IV
- 106.8%
- B/E move
- 2.1%
- Pseudo strike
- 62.84
- IV
- 43.0%
- B/E move
- 0.7%
Options history
Table
| Date | IV (%) |
|---|---|
| 55.87% | |
| 55.21% | |
| 61.37% | |
| 50.19% | |
| 49.69% | |
| 49.92% | |
| 50.49% | |
| 50.81% | |
| 50.38% | |
| 51.66% | |
| 53.78% | |
| 54.06% | |
| 52.67% | |
| 52.94% | |
| 58.04% | |
| 67.19% | |
| 73.89% | |
| 57.08% | |
| 57.38% | |
| 57.14% | |
| 58.72% | |
| 72.86% | |
| 73.80% | |
| 79.00% | |
| 83.69% | |
| 81.98% | |
| 81.44% | |
| 78.52% | |
| 82.01% | |
| 77.10% | |
| 92.62% | |
| 96.66% | |
| 76.00% | |
| 75.07% | |
| 77.84% | |
| 74.49% | |
| 76.92% | |
| 83.15% | |
| 55.43% | |
| 52.45% | |
| 51.34% |
Medical Devices
BBNX
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of…
More →BFLY
Butterfly Network, Inc., a digital health company, develops, manufactures, and markets ultrasound imaging solutions in the United States and internationally. The company is…
More →BIO
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets.
More →BRKR
Bruker Corporation develops, manufactures and distributes scientific instruments and analytical and diagnostic solutions in the United States, Europe, Asia Pacific, and…
More →BSX
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional…
More →BVS
Bioventus Inc., a medical device company, focuses on developing and commercializing clinical treatments that involve and enhance the body's natural healing process in the United…
More →